Search

Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.

CMSC Abstracts Search Form (Titles and Authors only)

Search Accepted Abstracts
Sending

Search Results

Year ID Type Category Title Authors
2021 QOL26 Poster Quality of Life and Outcomes

Multiple Sclerosis, Cognition and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability

Olivia Kaczmarek, BS1, Jack Petroski, Student2, Colette Kodym, Student2, Avtej Sethi, MS2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1,3, Myassar Zarif, MD1, Daniel Golan, MD4, Jeffrey Wilken, PhD5 and Mark Gudesblatt, MD6, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Stony Brook University, Stony Brook, NY, (4)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (5)Washington Neuropsychology Research Group, Washington, DC, (6)South Shore Neurologic Associates, P.C., Islip, NY

2021 QOL27 Poster Quality of Life and Outcomes

Multiple Sclerosis and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability

Olivia Kaczmarek, BS1, Ellie Teng, Student2, Fatima Khan, Student2, Avtej Sethi, MS2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1, Myassar Zarif, MD1, Daniel Golan, MD3, Jeffrey Wilken, PhD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, P.C., Islip, NY

2021 QOL28 Poster Quality of Life and Outcomes

Characterizing Activities of Daily Living in MS Patients with Processing Speed Scores Above and below a Threshold Previously Shown to Predict Employment Status

Ralph H.B. Benedict, PhD1, Arman Altincatal, MS2, Enrique Alvarez, MD, PhD, MSCI3, Deborah Backus, PT, PhD4, Martin Belkin, DO5, Sophie Cleanthous, PhD6, Joanna Cooper, MD7, Jessica Craddock, MD8, Carl de Moor, PhD2, Emma Elliott, BSc6, John Foley, MD9, Mehul Jhaveri, PharmD, MPH2, Gabriel Pardo, MD, FAAN10, Christopher Perrone, MD11, Pavle Repovic, MD, PhD12, Marvin Rock, -2, Suma Shah, MD13, Barry A Singer, MD14, Jacob A Sloane, MD PhD15, Kyle E. Smoot, MD16, Carlo Tornatore, MD17, Bianca Weinstock-Goodman, MD18 and Irene Koulinska, MD, ScD2, (1)Jacobs Multiple Sclerosis Center, University at Buffalo, Buffalo, NY, (2)Biogen, Cambridge, MA, (3)Department of Neurology, University of Colorado, Aurora, CO, (4)MS Research, Shepherd Center, Atlanta, GA, (5)Michigan Institute for Neuro Disorders, Farmington Hills, MI, (6)Modus Outcomes, Letchworth Garden City, United Kingdom, (7)East Bay Neurology, Walnut Creek, CA, (8)Providence Sacred Heart Medical Center – Spokane, Spokane, WA, (9)Rocky Mountain MS Clinic, Salt Lake City, UT, (10)Oklahoma Medical Research Foundation, Oklahoma City, OK, (11)OMRF Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, (12)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (13)Neurology, Duke University, Durham, NC, (14)Barnes Jewish Hospital, St Louis, OH, (15)Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, (16)Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, (17)Department of Neurology, Medstar Georgetown University Hospital, Washington, DC, (18)Jacobs Multiple Sclerosis Center, University of Buffalo, Buffalo, NY

2021 QOL29 Poster Quality of Life and Outcomes

A Coach Supported Standardized Approach for Quality Improvement (QI) in the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative.

Randall S Messier, MT, MSA, PCMH CCE, RandyMessierLLC, Fairfield, VT, Falguni Mehta, MS, MBA, Department of Community & Family Medicine, Dartmouth Hitchcock Health, Lebanon, NH and Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth, Lebanon, NH

2021 QOL30 Poster Quality of Life and Outcomes

Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis

Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY and Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO

2021 QOL31 Poster Quality of Life and Outcomes

The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care

Roma Amin, PharmD, BCACP1, LaTasha Riddick, PharmD, BCACP1, Amy Nathanson, PharmD, BCACP1 and Scott D. Newsome, DO, MSCS, FAAN, FANA2, (1)Johns Hopkins Homecare Group, Baltimore, MD, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

2021 QOL32 Poster Quality of Life and Outcomes

Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS

Susanne Clinch, PhD1, Fiona McDougall, PhD2, Amy Barrett, MSPH, MA3, Oyebimpe Olayinka-Amao, PharmD, MPH3, Licinio Craveiro, MD, MSc, PhD4, Mike Baker, BSc, MSc4 and Michael Lindemann, MD, PhD4, (1)Roche Products Limited, Welwyn Garden City, United Kingdom, (2)Genentech, Inc., South San Francisco, CA, (3)RTI Health Solutions, Research Triangle Park, NC, (4)F. Hoffmann-La Roche Ltd, Basel, Switzerland

2021 QOL33 Poster Quality of Life and Outcomes

Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes

Suzanne Croll, BSc1, Omar M Said, BS1,2, Marta Zholobetska, BS1, Lonni Schultz, PhD3 and Mirela Cerghet, MD, PhD2, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI, (3)Public Health Science, Henry Ford Health System, Detroit, MI

2021 QOL35 Poster Quality of Life and Outcomes

Patient-Reported Outcome Measures in Multiple Sclerosis Clinical Trials: Critical Assessment and Insights from People Living with Multiple Sclerosis

2021 QOL36 Poster Quality of Life and Outcomes

Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis

2021 QOL37 Poster Quality of Life and Outcomes

Understanding Health and Well-Being of Women with MS: Implications for Health Care Providers

Jennifer L Howard, PhD(c)., RN, Faculty of Nursing, Memorial University of Newfoundland, St. John’s, NF, Canada, Yolanda Babenko-Mould, PhD, RN, Health Science-Nursing, Western University, London, ON, Canada, Kimberley Jackson, PhD, RN, Health Science- Nursing, Western University, London, ON, Canada and Tracy Smith-Carrier, PhD, RSW, Social Work, King’s University College at Western University, London, ON, Canada

2021 QOL38 Poster Quality of Life and Outcomes

Coping Moderates the Association between Symptoms and Functional and Affective Outcomes in the Daily Lives of Individuals with Multiple Sclerosis

Thomas R Valentine, PhD, Duygu Kuzu, PhD and Anna L Kratz, PhD, Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI

2021 QOL39 Poster Quality of Life and Outcomes

Multiple Sclerosis Specialist Nurse Care: Patterns of Access and Impact on Health Outcomes

Belinda Bardsley, RN BN MSCN Dip Management1,2, Therese V Burke, PhD RN CNC3, Jing Chen, PhD4, Bruce Taylor, MD FRACP4, Sue Shapland, RN BN MSCN5 and Ingrid van der Mei, PhD4, (1)Neurology, Austin Health, Heidelberg, VIC, Australia, (2)MS Nurses Australasia Incorporated, Melbourne, Australia, (3)MS Research Australia, North Sydney, Australia, (4)Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, (5)MSWA, Perth, Australia

2021 REH09 Poster Rehabilitation Poster

Attitude and Perception of Multiple Sclerosis Patients Toward Exercise

Ali Fuad Ashour, PhD and Ali Fuad Ashour, PhD, Ministry of Education, Kuwait, Kuwait

2021 REH10 Poster Rehabilitation Poster

Is Depression Associated with Volume and Pattern of Sedentary Behavior in Persons with Multiple Sclerosis?

2021 REH11 Poster Rehabilitation Poster

A Scoping Review of Task-Oriented Exercise Effects on Motor Function in People with Multiple Sclerosis

Eduardo A Toledo-Aldana, BSc, Kristen E Plandowski, BSc and Cameron S Mang, PhD, Kinesiology and Health Studies, University of Regina, Regina, SK, Canada

2021 REH12 Poster Rehabilitation Poster

Physical Activity Vital Sign in Multiple Sclerosis

Gloria Hou, MD1, Jami Montagnino, MD1, Marcia Ciol, Ph.D.1 and Cindy Lin, MD1,2, (1)University of Washington, Seattle, WA, (2)The Sports Institute, Seattle, WA

2021 REH13 Poster Rehabilitation Poster

Difference in Lower Limb Strength Asymmetry between Fallers and Non-Fallers with Multiple Sclerosis

Heather M DelMastro, MSc1,2, Elizabeth S Gromisch, PhD1,3,4 and Jennifer A. Ruiz, DPT1,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

2021 REH14 Poster Rehabilitation Poster

Assessing the Benefits of Using Telehealth in Conjunction with a Fitbit to Improve Walking in Veterans with Multiple Sclerosis

Kelley Volpenhein, PT, DPT1, Amy Banks, PT, DPT, NCS, CBIS1, Lindsay J Riegler, Ph.D.2, Sarah Kiefer-Luhring, MA, CCC-SLP, ATP1 and Amy Kunce, MS, BSRS, CNMT3, (1)Cincinnati VAMC, Cincinnati, OH, (2)Rehab Care Line, Cincinnati VA Medical Center, Cincinnati, OH, (3)Neurology, VAMC, Baltimore, MD

2021 REH15 Poster Rehabilitation Poster

Occupational Therapy Delivered Emotional Regulation Interventions: A Case-Series of Female Patients with Multiple Sclerosis

Rebecca Cunningham, OTD, OTR/L, MSCS, Mrs. T.H. Chan Division of Occupational Science & Occupational Therapy, University of Southern California, Los Angeles, CA and Kristin McConnell, MA, OTS, Mrs. T.H. Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA

2021 REH16 Poster Rehabilitation Poster

A Review of Participant Characteristics in Theory-Based Physical Activity Behavior Change Programs in MS: Missing the Greatest Potential for Lifelong Benefits

Trinh Huynh, MPH1, Stephanie L Silveira, PhD2 and Robert W Motl, PhD1, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)Kinesiology, University of North Texas, Denton, TX

2021 REH17 Poster Rehabilitation Poster

Needs and Perceptions of a Mobile Application Based on the Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis in the United States

Whitney N Neal, MA, CHES1, Emma V Richardson, PhD2 and Robert W Motl, PhD1, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)University of Worcester, Worcester, United Kingdom

2021 REH18 Poster Rehabilitation Poster

Contradictory Roles of Exercise Participation: A Qualitative Synthesis

Brynn Adamson, PhD, Health Sciences, University of Colorado Colorado Springs, Colorado Springs, CO and Robert W Motl, PhD, Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

2021 REH19 Poster Rehabilitation Poster

Validation and Minimal Detectable Change of the Walking While Talking Test As a Measure of Dual-Task Performance in Ambulatory Individuals with Multiple Sclerosis

David A Henning, PhD1, Erin M Edwards, B.S.1, Melissa Ansara, undergraduate2 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Physical Therapy, Wayne State University, Detroit, MI

2021 REH20 Poster Rehabilitation Poster

Characterizing the Relationship between Neurological/Mental Health and Physical Activity Levels in Persons with Multiple Sclerosis

Emily E Tyszka, MPH, Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH and Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH

2021 REH21 Poster Rehabilitation Poster

Effects of Extended Photobiomodulation Therapy on Muscle Performance in Persons with Relapsing-Remitting Multiple Sclerosis

Mitra Rouhani, M.S.1, Miguel Tolentino, Ph.D.2, Erik Queoff, M.S.1, Chris Cho, Ph.D.2, Jeri-Anne Lyons, Ph.D.2,3 and Alexander V Ng, PhD4, (1)Marquette University, Milwaukee, WI, (2)University of Wisconsin-Milwaukee, Milwaukee, WI, (3)University of Northern Colorado, Greeley, CO, (4)Exercise Science, Marquette University, Milwaukee, WI

2021 RTH01 Poster Relapse Therapy

Long-Term Safety of Satralizumab in Neuromyelitis Optica Spectrum Disorder: Results from the Open-Label Extension Periods of Sakurasky and Sakurastar

2021 RTH02 Poster Relapse Therapy

Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis

Daniel Wynn, MD1, Lawrence P Goldstick, MD2, William Bauer, MD, PhD3, Enxu Zhao, MS4, Eva Tarau, MD4, Jeffrey A. Cohen, MD5, Derrick Robertson, MD6 and Aaron E Miller, MD7, (1)Consultants in Neurology MS Center, Northbrook, IL, (2)Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH, (3)Department of Neurosciences, University of Toledo, Toledo, OH, (4)Mallinckrodt Pharmaceuticals, Hampton, NJ, (5)Department of Neurology, Mellen MS Center, Neurological Instiute,Cleveland Clinic, Cleveland, OH, (6)University of South Florida, Morsani College of Medicine, Tampa, FL, (7)Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY

2021 SEC01 Poster Self-care

Summary of Diet Intervention Studies in Multiple Sclerosis from the National MS Society Nutrition Wellness Subgroup

Rebecca I Spain, MD, MSPH, Oregon Health & Science University, Portland, OR; VA Portland Health Care System, Portland, OR, Mona Bostick, RDN, LDN, MSCS, NA, Greensboro, NC, Patrizia Casaccia, MD, PhD, Advanced Science Research Center, City University of New York, New york, NY, Kathryn C Fitzgerald, ScD, Johns Hopkins Medicine, Department of Neurology, Baltimore, MD, Barbara Giesser, MD, Neurology, UCLA, Los Angeles, CA, Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, Laura Piccio, MD/PhD, Neurology, Washington University, St Louis, MO, Terry L. Wahls, MD, Department of Internal Medicine, University of Iowa, Iowa City, IA, Brooks C Wingo, PhD, Department of Occupational Therapy, University of Alabama, Birmingham, AL, Vijayshree Yadav, MD, Neurology, Oregon Health & Science University, Portland, OR, Kathleen M Zackowski, PhD, OT, Motion Analysis Laboratory, Kennedy Krieger Institute, Baltimore, MD and Ilana Katz Sand, MD, Neurology, The Mount Sinai Hospital, New York, NY

2021 SXM01 Poster Symptom Management

Arbaclofen Extended-Release for the Treatment of Spasticity in Multiple Sclerosis: A Randomized, Multi-Center, Placebo-Controlled Clinical Trial (Study OS440-3004)

Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Mark Jaros, PhD, Summit Analytical, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX

2021 SXM02 Poster Symptom Management

The Effect of Hypnotics and Stimulants on Fatigue, Sleep, and Quality of Life Outcomes in a Multiple Sclerosis Cohort

Daniela A Pimentel Maldonado, MD1, Loulwah Mukharesh, MD2, Chen Hu, MS1, Ellen M Mowry, MD, MCR1, Bardia Nourbakhsh, MD1 and Kathryn C Fitzgerald, ScD1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neuro-Ophthalmology, Massachusetts Eye and Ear Institute, Boston, MA

2021 SXM03 Poster Symptom Management

Arbaclofen Extended-Release for the Treatment of Spasticity in Multiple Sclerosis: An Open-Label Safety Study (Study OS440-3005)

Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX, Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, Mark Jaros, PhD, Summit Analytical, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN

2021 SXM04 Poster Symptom Management

Nabiximols, a Cannabis-Based Complex Botanical Mixture and MS Spasticity: How Does It Work?

Kathryn Nichol, PhD, Greenwich Biosciences, Inc., Carlsbad, CA and Royston Gray, PhD, Pharmacology Scientist, GW Research Ltd, London, United Kingdom

2021 SXM05 Poster Symptom Management

Systematic Review of Real-World Evidence on the Effect of Nabiximols on Pain and Sleep Impairment in Persons with MS (PwMS) Experiencing Spasticity

Mary A. Willis, MD1, Kate Nichol, PhD2 and Kelly Hollenack, PharmD2, (1)Department of Neurology, University of Mississippi Medical Center, Jackson, MS, (2)Greenwich Biosciences, Inc., Carlsbad, CA

2021 SXM06 Poster Symptom Management

Identifying and Characterizing Fatigue in Patients Diagnosed with Multiple Sclerosis on Disease-Modifying Therapies Using Real World Evidence

Thomas P. Leist, MD1, Michele Cole, PharmD, MS2, Hoa Le, PhD3, Sumit Verma, BPharm, MS4 and Alex Keenan, MS2, (1)Comprehensive Multiple Sclerosis Center, Division of Clinical Neuroimmunology, Jefferson University, Philadelphia, PA, (2)Research and Development, Janssen Pharmaceuticals, Titusville, NJ, (3)Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, (4)Health Economics and Outcomes Research, StatInMed, Plano, TX

2021 SXM07 Poster Symptom Management

Is a Light Hand on the Wheels Enough? Postural Sway in Standing with Different Methods of Walker Use in Multiple Sclerosis and Controls

Najala Orrell, MD1, Pawan Kumar, PhD Student2, Alison Oates, PhD2, Joel Lanovaz, PhD2, Michael Levin, FRCPC3, Aman Saini, MD3 and Katherine Knox, FRCPC1, (1)Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (2)College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada

2021 SXM08 Poster Symptom Management

Sources of Cannabis Information and Medical Guidance Among People with Multiple Sclerosis: Narcoms Survey Results

Robert J. Fox, MD1, Amber Salter, PhD2, Gary Cutter, PhD3, Joshua R. Steinerman, MD4, Kate Nichol, PhD4 and Karry Smith, PhD, MPH4, (1)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (2)Washington University School in St. Louis, St Louis, MO, (3)The University of Alabama at Birmingham, Birmingham, AL, (4)Greenwich Biosciences, Inc., Carlsbad, CA

2021 SXM09 Poster Symptom Management

Arbaclofen Extended-Release for Spasticity in Multiple Sclerosis: Responder Analysis of a Phase 3 Randomized, Placebo-Controlled Clinical Study OS440-3004

Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, James L Rogers, PhD, Summit Analytical LLC, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX

2021 SXM10 Poster Symptom Management

Symptom Burden and Treatment Goals of People with MS Spasticity: Results from SEEN-MSS, a Large-Scale, Self-Reported Survey

Scott D. Newsome, DO, MSCS, FAAN, FANA1, Ben Thrower, MD2, Barry Hendin, MD3, Joanne Wagner, PT, PhD4, Sherry Danese, PhD5 and Jenifer Patterson, ARNP, MSCN4, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Andrew C. Carlos MS Institute, Shepherd Center, Atlanta, GA, (3)Neurology, University of Arizona, Tucson, AZ, (4)Greenwich Biosciences, Carlsbad, CA, (5)Outcomes Insights, Agoura Hills, CA

2021 SXM11 Poster Symptom Management

Implementation of a Depression Screening Tool (PHQ-9) for Adult Multiple Sclerosis Patients at an Outpatient Neurology Clinic.

Selina Yeasmin, CRNP, Outpatient Neurology Department, UMMC, Baltimore, MD and Lori Edwards, DrPH, BSN, RN